RHHBY•benzinga•
Roche To Start Phase 3 Study For Alzheimer's Prospect This Year After New Data From Phase 2
Summary
Roche's trontinemab data showed dose-dependent amyloid reduction in Alzheimer's patients, while its Elecsys pTau181 test aims for European launch in 2025
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 4, 2025 by benzinga